The use of biologic medications for the treatment of cutaneous immune-related adverse events secondary to immune checkpoint inhibitors: A single-institution real-life study par Jade N. Young, BS, Hannah Verma, BA, Nour El Kashlan, MD, Dina Poplausky, BA, Angela J. Lamb, MD, Emma Guttman-Yassky, MD, PhD, Nicholas Gulati, MD, PhD

Accéder au texte intégral

A case of urticarial vasculitis associated with atezolizumab par Jade N. Young, BS, Ryan Rivera-Oyola, MD, Dina Poplausky, BA, Yamato Suemitsu, MD, Randie H. Kim, MD, PhD, Deborah Doroshow, MD, PhD, Nicholas Gulati, MD, PhD

Accéder au texte intégral